Qvt Financial LP Clovis Oncology, Inc. Transaction History

Qvt Financial LP

  • $1.04 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.05 - $2.85 $1.5 Million - $4.06 Million
1,425,000 Added 67.86%
3,525,000 $4.2 Million
Q2 2022

Aug 15, 2022
BUY
$0.63 - $2.96 $1 Million - $4.72 Million
1,595,000 Added 315.84%
2,100,000 $3.78 Million
Q4 2021

Feb 14, 2022
BUY
$2.7 - $4.76 $1.36 Million - $2.4 Million
505,000 New
505,000 $1.37 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Qvt Financial LP Portfolio

Follow Qvt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Qvt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email